• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期摄入尼古丁可减缓黑质纹状体多巴胺能神经元的衰老。

Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons.

作者信息

Prasad C, Ikegami H, Shimizu I, Onaivi E S

机构信息

Department of Medicine, Louisiana State University Medical Center, New Orleans 70112.

出版信息

Life Sci. 1994;54(16):1169-84. doi: 10.1016/0024-3205(94)00839-6.

DOI:10.1016/0024-3205(94)00839-6
PMID:8152341
Abstract

We have evaluated the effect of chronic nicotine intake on the age-associated loss of nigrostriatal dopaminergic neurons. The striatal density of dopamine (D1 and D2) receptors and DA-uptake sites decreased with age. Concomitant with these changes was a pronounced loss of many behavioral functions associated, at least in part, with dopaminergic neurotransmission. Chronic oral intake of nicotine resulted in partial restoration of the loss of receptors as well as behavioral performances. The results suggest that low doses of nicotine could have beneficial effects during aging.

摘要

我们评估了长期摄入尼古丁对与年龄相关的黑质纹状体多巴胺能神经元丧失的影响。多巴胺(D1和D2)受体以及多巴胺摄取位点的纹状体密度会随着年龄增长而降低。与这些变化同时出现的是许多行为功能的显著丧失,这些行为功能至少部分与多巴胺能神经传递有关。长期口服尼古丁可使受体丧失以及行为表现得到部分恢复。结果表明,低剂量尼古丁在衰老过程中可能具有有益作用。

相似文献

1
Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons.长期摄入尼古丁可减缓黑质纹状体多巴胺能神经元的衰老。
Life Sci. 1994;54(16):1169-84. doi: 10.1016/0024-3205(94)00839-6.
2
Is nicotine protective against Parkinson's disease? An experimental analysis.尼古丁对帕金森病有保护作用吗?一项实验分析。
CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):897-906. doi: 10.2174/1871527311201070897.
3
Neuropeptide-dopamine interactions. IV. Effect of thyrotropin-releasing hormone on striatal dopaminergic neurons.神经肽 - 多巴胺相互作用。IV. 促甲状腺激素释放激素对纹状体多巴胺能神经元的影响。
Peptides. 1989 May-Jun;10(3):681-5. doi: 10.1016/0196-9781(89)90159-9.
4
Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.重复给予 D1 多巴胺受体激动剂可预防去神经支配后 D1 和 D2 纹状体受体超敏反应的发生。
Synapse. 1992 Mar;10(3):206-16. doi: 10.1002/syn.890100304.
5
The role of dopamine receptors in regulating the size of axonal arbors.多巴胺受体在调节轴突分支大小中的作用。
J Neurosci. 2001 Jul 15;21(14):5147-57. doi: 10.1523/JNEUROSCI.21-14-05147.2001.
6
Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.为增强对阿扑吗啡的敏感性而培育的大鼠,其黑质纹状体和结节漏斗多巴胺系统中的酪氨酸羟化酶mRNA和多巴胺D2受体结合位点有所升高。
Brain Res. 1996 Feb 26;710(1-2):189-96. doi: 10.1016/0006-8993(95)01379-2.
7
Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
J Pharm Pharmacol. 1992 Feb;44(2):89-92. doi: 10.1111/j.2042-7158.1992.tb03567.x.
8
6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.6-羟基多巴胺诱导的黑质多巴胺能神经元变性:对黑质和纹状体D-1多巴胺受体的不同影响。
Life Sci. 1987 Aug 10;41(6):697-706. doi: 10.1016/0024-3205(87)90449-8.
9
Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.有实验性帕金森症症状并已康复的猫的多巴胺摄取位点以及D1和D2受体的变化。
Synapse. 1995 Jan;19(1):46-55. doi: 10.1002/syn.890190107.
10
Activation by nicotine of striatal neurons receiving excitatory input from the substantia nigra via dopamine release.
Brain Res. 2000 Jul 28;872(1-2):223-6. doi: 10.1016/s0006-8993(00)02463-x.

引用本文的文献

1
Epidemiology of Parkinson's disease.帕金森病的流行病学
Handb Clin Neurol. 2007;83:129-51. doi: 10.1016/S0072-9752(07)83006-5.
2
Transdermal treatment options for neurological disorders: impact on the elderly.神经系统疾病的经皮治疗选择:对老年人的影响。
Drugs Aging. 2006;23(5):357-75. doi: 10.2165/00002512-200623050-00001.
3
A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines.
Neurochem Res. 1996 Oct;21(10):1181-6. doi: 10.1007/BF02532393.
4
Epidemiology of Parkinson's disease.帕金森病的流行病学
Neurol Clin. 1996 May;14(2):317-35. doi: 10.1016/S0733-8619(05)70259-0.
5
Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.烟碱型受体在神经退行性疾病中作用的遗传和环境因素:重点关注阿尔茨海默病和帕金森病
Behav Genet. 1995 Mar;25(2):149-59. doi: 10.1007/BF02196924.